Justin D. Pitt - Mar 15, 2024 Form 4 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Role
EVP and General Counsel
Signature
Christopher G. Cobb, Attorney in Fact for Justin D. Pitt
Stock symbol
CYH
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/15/2024, 04:31 PM
Previous filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYH Common Stock Disposed to Issuer $0 -5K -28.44% $0.00 12.6K Mar 15, 2024 By spouse F1
holding CYH Common Stock 208K Mar 15, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYH Performance Based Restricted 30K Mar 15, 2024 Common Stock 30K $0.00 Direct F2
holding CYH Performance Based Restricted 30K Mar 15, 2024 Common Stock 30K $0.00 Direct F3
holding CYH Performance Based Restricted 30K Mar 15, 2024 Common Stock 30K $0.00 Direct F4
holding CYH Stock Options (Right to Buy) 5K Mar 15, 2024 Common Stock 5K $4.99 Direct
holding CYH Stock Options (Right to Buy) 20K Mar 15, 2024 Common Stock 20K $4.93 Direct
holding CYH Stock Options (Right to Buy) 20K Mar 15, 2024 Common Stock 20K $8.81 Direct
holding CYH Stock Options (Right to Buy) 30K Mar 15, 2024 Common Stock 30K $10.18 Direct F5
holding CYH Stock Options (Right to Buy) 30K Mar 15, 2024 Common Stock 30K $6.15 Direct F5
holding CYH Stock Options (Right to Buy) 30K Mar 15, 2024 Common Stock 30K $2.87 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
F3 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
F4 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
F5 Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.